CD4 cells can be more efficient at tumor rejection than CD8 cells

Researchers designing antitumor treatments have long focused on eliciting tumor-specific CD8 cytotoxic T lymphocytes (CTL) because of their potent killing activity and their ability to reject transplanted organs. The resulting treatments, however, have generally been surprisingly poor at inducing co...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Perez-Diez, Ainhoa, Joncker, Nathalie T., Choi, Kyungho, Chan, William F. N., Anderson, Colin C., Lantz, Olivier, Matzinger, Polly
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2007
Ämnen:
Immunobiology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1890845/
https://ncbi.nlm.nih.gov/pubmed/17327412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-10-051318
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk